FI120256B - Menetelmä uusien terapeuttisesti aktiivisten 3,3-difenyylipropyyliamiinien valmistamiseksi ja välituotteita - Google Patents
Menetelmä uusien terapeuttisesti aktiivisten 3,3-difenyylipropyyliamiinien valmistamiseksi ja välituotteita Download PDFInfo
- Publication number
- FI120256B FI120256B FI952179A FI952179A FI120256B FI 120256 B FI120256 B FI 120256B FI 952179 A FI952179 A FI 952179A FI 952179 A FI952179 A FI 952179A FI 120256 B FI120256 B FI 120256B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- hydroxy
- group
- hydrogen
- diphenylpropylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Luminescent Compositions (AREA)
- Photoreceptors In Electrophotography (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9203318A SE9203318D0 (sv) | 1992-11-06 | 1992-11-06 | Novel 3,3-diphenylpropylamines, their use and preparation |
SE9203318 | 1992-11-06 | ||
SE9300927 | 1993-11-05 | ||
PCT/SE1993/000927 WO1994011337A1 (en) | 1992-11-06 | 1993-11-05 | Novel 3,3-diphenylpropylamines, their use and preparation |
Publications (3)
Publication Number | Publication Date |
---|---|
FI952179A FI952179A (fi) | 1995-05-05 |
FI952179A0 FI952179A0 (fi) | 1995-05-05 |
FI120256B true FI120256B (fi) | 2009-08-31 |
Family
ID=20387730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI952179A FI120256B (fi) | 1992-11-06 | 1995-05-05 | Menetelmä uusien terapeuttisesti aktiivisten 3,3-difenyylipropyyliamiinien valmistamiseksi ja välituotteita |
Country Status (15)
Country | Link |
---|---|
US (4) | USRE39667E1 (no) |
EP (1) | EP0667852B1 (no) |
JP (1) | JP3343256B2 (no) |
AT (1) | ATE164828T1 (no) |
AU (1) | AU672458B2 (no) |
CA (1) | CA2148827C (no) |
DE (1) | DE69317898T2 (no) |
DK (1) | DK0667852T3 (no) |
ES (1) | ES2117155T3 (no) |
FI (1) | FI120256B (no) |
HK (1) | HK1006349A1 (no) |
HU (1) | HU224916B1 (no) |
NO (1) | NO305477B1 (no) |
SE (1) | SE9203318D0 (no) |
WO (1) | WO1994011337A1 (no) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9203318D0 (sv) | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
US6207681B1 (en) | 1996-07-01 | 2001-03-27 | Sepracor Inc. | Methods and compositions for treating urinary incontinence using enantiomerically enriched (R)-trihexyphenidyl |
DE69720518T2 (de) * | 1996-12-02 | 2004-02-26 | Kyorin Pharmaceutical Co., Ltd. | Neue derivate von n-substituierten pyrrolidin derivaten und deren herstellungsverfahren |
SE9701144D0 (sv) * | 1997-03-27 | 1997-03-27 | Pharmacia & Upjohn Ab | Novel compounds, their use and preparation |
EP0957073A1 (en) * | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | Novel derivatives of 3,3-diphenylpropylamines |
EA002720B1 (ru) | 1998-08-27 | 2002-08-29 | Фармациа Энд Апджон Аб | Терапевтическая композиция для введения толтеродина с контролируемым высвобождением и способ лечения мочевого пузыря с её использованием |
CZ304671B6 (cs) | 1999-11-11 | 2014-08-27 | Pharmacia Ab | Farmaceutický prostředek obsahující tolterodin a jeho použití |
DE29923134U1 (de) * | 1999-11-16 | 2000-06-29 | Sanol Arznei Schwarz Gmbh | Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen |
SE9904850D0 (sv) * | 1999-12-30 | 1999-12-30 | Pharmacia & Upjohn Ab | Novel process and intermediates |
AU4274401A (en) | 2000-03-24 | 2001-10-03 | Meiji Seika Kaisha | Diphenylalkylamine derivatives useful as opioid delta receptor agonists |
DE10028443C1 (de) * | 2000-06-14 | 2002-05-29 | Sanol Arznei Schwarz Gmbh | Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen |
DE10033016A1 (de) * | 2000-07-07 | 2002-01-24 | Sanol Arznei Schwarz Gmbh | Verfahren zur Herstellung von 3,3-Diarylpropylaminen |
PE20020547A1 (es) | 2000-10-24 | 2002-06-12 | Upjohn Co | Uso de la tolterodina en tratamientos del asma |
JP4959907B2 (ja) * | 2001-03-27 | 2012-06-27 | ワーナー チルコット(アイルランド)リミティド | 抗菌剤投与のための膣内用ドラッグデリバリーデバイス |
US20030027856A1 (en) * | 2001-06-29 | 2003-02-06 | Aberg A.K. Gunnar | Tolterodine metabolites |
US20030060513A1 (en) * | 2001-09-27 | 2003-03-27 | Arneric Stephen P. | Pharmaceutical composition |
JP3981357B2 (ja) * | 2001-10-26 | 2007-09-26 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 第4級アンモニウム化合物および抗ムスカリン剤としてのそれらの使用 |
CA2464217A1 (en) * | 2001-11-05 | 2003-05-15 | Pharmacia & Upjohn Company | Antimuscarinic aerosol |
EP1441707A1 (en) * | 2001-11-09 | 2004-08-04 | Pharmacia AB | Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder |
US20030152624A1 (en) * | 2001-12-20 | 2003-08-14 | Aldrich Dale S. | Controlled release dosage form having improved drug release properties |
EP2266590A3 (en) | 2002-02-22 | 2011-04-20 | Shire LLC | Active agent delivery sytems and methods for protecting and administering active agents |
US7005449B2 (en) * | 2002-04-23 | 2006-02-28 | Pharmacia & Upjohn Company | Tolterodine salts |
EP1546099B1 (en) * | 2002-07-08 | 2008-12-31 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
US7825132B2 (en) | 2002-08-23 | 2010-11-02 | Novartis Vaccines And Diagnostics, Inc. | Inhibition of FGFR3 and treatment of multiple myeloma |
WO2004043389A2 (en) * | 2002-11-13 | 2004-05-27 | Chiron Corporation | Methods of treating cancer and related methods |
DE10315917A1 (de) * | 2003-04-08 | 2004-11-18 | Schwarz Pharma Ag | Hochreine Basen von 3,3-Diphenylpropylaminmonoestern |
EP1618091A1 (en) * | 2003-04-09 | 2006-01-25 | Ranbaxy Laboratories, Ltd. | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
NZ542952A (en) * | 2003-04-11 | 2008-11-28 | Ranbaxy Lab Ltd | Azabicyclo derivatives as muscarinic receptor antagonists |
EP1620389A1 (en) | 2003-04-25 | 2006-02-01 | Pharmacia & Upjohn Company LLC | Halogen substituted 3,3-diphenylpropylamines (tolterodine) having antimuscarinic activity |
AU2004243005B2 (en) * | 2003-05-23 | 2009-09-03 | Bridge Pharma, Inc. | Smooth muscle spasmolytic agents |
WO2005012227A2 (en) * | 2003-08-05 | 2005-02-10 | Ranbaxy Laboratories Limited | Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine |
ES2235648B1 (es) * | 2003-12-22 | 2006-11-01 | Ragactives, S.L. | Procedimiento para la obtencion de tolterodina. |
WO2005061432A1 (en) * | 2003-12-24 | 2005-07-07 | Cipla Limited | Tolterodine, compositions and uses thereof, and preparation of the same |
CN1960731B (zh) | 2004-02-20 | 2011-12-07 | 诺华疫苗和诊断公司 | 调节炎性和转移过程的方法 |
EP1629834A1 (en) | 2004-08-27 | 2006-03-01 | KRKA, D.D., Novo Mesto | Sustained release pharmaceutical composition of tolterodine |
US20100035954A1 (en) * | 2004-12-15 | 2010-02-11 | Mohammad Salman | Acid addition salts of muscarinic receptor antagonists |
TW200640839A (en) * | 2005-01-10 | 2006-12-01 | Teva Pharma | Process for preparing Tolterodine tartrate |
US20080319043A1 (en) * | 2005-05-03 | 2008-12-25 | Mohammad Salman | 3,6-Disubstituted Azabicyclo (3.1.0) Hexane Derivatives as Muscarinic Receptor Antagonists |
JP5344910B2 (ja) | 2005-05-13 | 2013-11-20 | ノバルティス アーゲー | 薬剤耐性癌の処置方法 |
RU2008120332A (ru) * | 2005-12-20 | 2010-01-27 | Пфайзер Продактс Инк. (Us) | Фармацевтическая композиция для лечения luts, содержащая ингибитор pde5 и мускариновый антагонист |
CA2643097C (en) | 2006-03-20 | 2012-03-13 | Pfizer Limited | Amine derivatives |
EA016399B1 (ru) * | 2006-05-31 | 2012-04-30 | Шварц Фарма Лтд. | Способ синтеза замещенных гидроксиметилфенолов |
EP1862449A1 (en) * | 2006-05-31 | 2007-12-05 | Schwarz Pharma Ltd. | A shortened synthesis of substituted hydroxymethyl phenols |
IES20060424A2 (en) | 2006-06-08 | 2007-10-31 | Schwarz Pharma Ltd | Accelerated synthesis of (3-Diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol and its phenolic monoesters |
WO2007140986A1 (en) | 2006-06-09 | 2007-12-13 | Schwarz Pharma Ltd | Synthesis of phenolic esters of hydroxymethyl phenols |
IES20060435A2 (en) | 2006-06-12 | 2007-12-12 | Schwarz Pharma Ltd | Shortened synthesis using paraformaldehyde or trioxane |
AU2007260267B2 (en) | 2006-06-12 | 2012-09-06 | Ucb Pharma Gmbh | New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof |
BRPI0713314A2 (pt) | 2006-06-20 | 2012-03-06 | Lek Pharmaceuticals D.D. | Processo para a preparação de 3-(2-hidróxi-5-fenil substituído)-n-alquil-3-fenilpropilaminas |
US20100217034A1 (en) * | 2007-09-21 | 2010-08-26 | Actavis Group Ptc Ehf | Process for the Preparation of Fesoterodine |
KR101188333B1 (ko) * | 2008-02-20 | 2012-10-09 | 에스케이케미칼주식회사 | 안정성이 우수하고 경피제로 유용한 톨테로딘 결정성산부가염 |
US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
ES2533956T3 (es) * | 2009-05-11 | 2015-04-16 | Ratiopharm Gmbh | Desfesoterodina en forma de una sal de ácido tartárico |
IT1394219B1 (it) | 2009-05-15 | 2012-06-01 | Chemi Spa | Metodo di preparazione di fesoterodina fumarato di elevata purezza. |
IT1394217B1 (it) | 2009-05-15 | 2012-06-01 | Chemi Spa | Metodo di preparazione di fesoterodina e/o fesoterodina fumarato. |
EP2281801B1 (en) | 2009-07-27 | 2014-01-08 | Crystal Pharma, S.A.U. | Process for obtaining 3,3-diphenylpropylamines |
IT1396373B1 (it) | 2009-10-29 | 2012-11-19 | Dipharma Francis Srl | Procedimento per la preparazione di fesoterodina. |
IL210279A0 (en) | 2009-12-25 | 2011-03-31 | Dexcel Pharma Technologies Ltd | Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients |
EP2364966A1 (en) | 2010-03-09 | 2011-09-14 | LEK Pharmaceuticals d.d. | Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-3-phenylpropylamines, intermediates for making hydroxytolterodine |
WO2011141932A2 (en) | 2010-05-11 | 2011-11-17 | Intas Pharmaceuticals Limited | Process for preparation of phenolic monoesters of hydroxymethyl phenols |
WO2011145019A1 (en) * | 2010-05-17 | 2011-11-24 | Orchid Chemicals And Pharmaceuticals Limited | Improved process for diphenylpropylamine derivatives |
IT1401451B1 (it) | 2010-06-10 | 2013-07-26 | Chemi Spa | Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo. |
IT1403094B1 (it) | 2010-12-09 | 2013-10-04 | Dipharma Francis Srl | Procedimento per la preparazione di fesoterodina o un suo sale |
TWI520732B (zh) | 2011-01-18 | 2016-02-11 | 輝瑞有限公司 | 固體分子分散液 |
JP6234999B2 (ja) | 2012-05-04 | 2017-11-22 | クリスタル ファルマ、エセ、ア、ウCrystal Pharma,S.A.U. | 光学的に活性な3,3−ジフェニルプロピルアミンを調製するための方法 |
EP2760822B1 (en) | 2012-06-14 | 2016-03-23 | ratiopharm GmbH | Desfesoterodine salts |
ITMI20121232A1 (it) | 2012-07-16 | 2014-01-17 | Cambrex Profarmaco Milano Srl | Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati |
GB201402556D0 (en) | 2014-02-13 | 2014-04-02 | Crystec Ltd | Improvements relating to inhalable particles |
WO2016148444A1 (ko) * | 2015-03-17 | 2016-09-22 | 제이더블유중외제약 주식회사 | 신규 데스페소테로딘 유도체, 이의 약제학적으로 허용되는 염 및 이를 포함하는 약제학적 조성물 |
WO2017137955A1 (en) | 2016-02-14 | 2017-08-17 | Celestis Pharmaceuticals Pvt. Ltd. | Novel (r) and rac 3-(2-(allyloxy)-5-methylphenyl)-n,n-diisopropyl-3- phenylpropan-1-amine and its use for synthesis of (r) and rac-2-(3- (diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol |
CN110372571B (zh) | 2018-04-12 | 2022-11-15 | 中国科学院大连化学物理研究所 | 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK111894A (no) * | 1962-11-15 | |||
GB1169945A (en) * | 1966-08-25 | 1969-11-05 | Geistlich Soehne Ag | Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives |
GB1169944A (en) | 1966-08-25 | 1969-11-05 | Geistlich Soehne Ag | Novel 3,3-Diphenylpropylamines and processes for the preparation thereof |
US4139537A (en) | 1976-06-29 | 1979-02-13 | Cooper Laboratories, Inc. | 3-Aryloxy-1-(2- or 4-iminodihydro-1-pyridyl)-2-propanol antiarrhythmic compounds |
SE8800207D0 (sv) * | 1988-01-22 | 1988-01-22 | Kabivitrum Ab | Nya aminer, deras anvendning och framstellning |
US5382600A (en) * | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
SE9203318D0 (sv) | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
US5472958A (en) * | 1994-08-29 | 1995-12-05 | Abbott Laboratories | 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function |
PE20020547A1 (es) * | 2000-10-24 | 2002-06-12 | Upjohn Co | Uso de la tolterodina en tratamientos del asma |
-
1992
- 1992-11-06 SE SE9203318A patent/SE9203318D0/xx unknown
-
1993
- 1993-11-05 US US11/017,635 patent/USRE39667E1/en not_active Expired - Lifetime
- 1993-11-05 DE DE69317898T patent/DE69317898T2/de not_active Expired - Lifetime
- 1993-11-05 DK DK93924876T patent/DK0667852T3/da active
- 1993-11-05 AU AU54380/94A patent/AU672458B2/en not_active Expired
- 1993-11-05 US US11/402,337 patent/USRE40851E1/en not_active Expired - Lifetime
- 1993-11-05 HU HU9501329A patent/HU224916B1/hu unknown
- 1993-11-05 EP EP93924876A patent/EP0667852B1/en not_active Expired - Lifetime
- 1993-11-05 JP JP51197794A patent/JP3343256B2/ja not_active Expired - Lifetime
- 1993-11-05 WO PCT/SE1993/000927 patent/WO1994011337A1/en active IP Right Grant
- 1993-11-05 CA CA002148827A patent/CA2148827C/en not_active Expired - Lifetime
- 1993-11-05 ES ES93924876T patent/ES2117155T3/es not_active Expired - Lifetime
- 1993-11-05 AT AT93924876T patent/ATE164828T1/de active
-
1995
- 1995-05-05 US US08/432,113 patent/US5559269A/en not_active Ceased
- 1995-05-05 NO NO951775A patent/NO305477B1/no not_active IP Right Cessation
- 1995-05-05 FI FI952179A patent/FI120256B/fi not_active IP Right Cessation
-
1996
- 1996-07-22 US US08/684,638 patent/US5686464A/en not_active Expired - Lifetime
-
1998
- 1998-06-17 HK HK98105466A patent/HK1006349A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HU224916B1 (en) | 2006-04-28 |
EP0667852A1 (en) | 1995-08-23 |
HK1006349A1 (en) | 1999-02-19 |
ES2117155T3 (es) | 1998-08-01 |
DK0667852T3 (da) | 1999-01-11 |
CA2148827C (en) | 2005-01-04 |
DE69317898T2 (de) | 1998-10-15 |
FI952179A (fi) | 1995-05-05 |
US5559269A (en) | 1996-09-24 |
AU5438094A (en) | 1994-06-08 |
NO951775D0 (no) | 1995-05-05 |
USRE40851E1 (en) | 2009-07-14 |
DE69317898D1 (de) | 1998-05-14 |
WO1994011337A1 (en) | 1994-05-26 |
NO951775L (no) | 1995-05-05 |
ATE164828T1 (de) | 1998-04-15 |
FI952179A0 (fi) | 1995-05-05 |
JPH08503208A (ja) | 1996-04-09 |
USRE39667E1 (en) | 2007-05-29 |
HUT72742A (en) | 1996-05-28 |
EP0667852B1 (en) | 1998-04-08 |
CA2148827A1 (en) | 1994-05-26 |
SE9203318D0 (sv) | 1992-11-06 |
JP3343256B2 (ja) | 2002-11-11 |
AU672458B2 (en) | 1996-10-03 |
HU9501329D0 (en) | 1995-06-28 |
US5686464A (en) | 1997-11-11 |
NO305477B1 (no) | 1999-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI120256B (fi) | Menetelmä uusien terapeuttisesti aktiivisten 3,3-difenyylipropyyliamiinien valmistamiseksi ja välituotteita | |
WO1994011337A9 (en) | Novel 3,3-diphenylpropylamines, their use and preparation | |
USRE49811E1 (en) | Sphingosine kinase inhibitors | |
FI77018C (fi) | Analogifoerfarande foer framstaellning av antidepressivt aktiv (-)-enantiomer av n-metyl-n-/3-(2-metylfenoxi) -3-fenylpropyl/amin och dess farmaceutiskt godtagbara salt. | |
DK168761B1 (da) | Phenylethere og farmaceutisk acceptable salte deraf, fremgangsmåder til fremstilling heraf samt far maceutiske midler indeholdelde disse | |
JP6898310B2 (ja) | 6員アザヘテロ環を含有するデルタ−オピオイド受容体調節化合物、同化合物を使用する方法、および同化合物を作る方法 | |
US7119121B2 (en) | 3,3-diphenylpropylamines useful in therapy | |
US4960797A (en) | N-2[(4-fluoro-phenyl)-1-methyl]-2-ethyl-N-methyl-N-propynyl amine and the method of use thereof | |
AU707142B2 (en) | Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor | |
KR100295264B1 (ko) | 우울증,불안증및파킨슨씨병을치료하기위한1-아릴시클로알킬술피드,술폭시드및술폰 | |
US5149714A (en) | Antidepressants | |
EP1414425A1 (en) | Amine compounds and inhibiting neurotransmitter reuptake | |
US20040248987A1 (en) | Smooth muscle spasmolytic agents | |
EP0512525A1 (en) | Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent, central nervous system stimulant or sigma receptor agonist | |
SK7695A3 (en) | Pharmacologicaly active alpha-(tertiary-aminomethyl)-benzene methanol derivatives | |
PT95196A (pt) | Processo para a prparacao de n-benziltropanamidas | |
DK144299B (da) | Analogifremgangsmaade til fremstilling af 1-fenyl2-amino-1,3-propandiol-n-alkyl-derivater eller fysiologisk acceptable salte deraf | |
KR820001235B1 (ko) | 알킬티오페녹시프로파놀아민의 제조방법 | |
NO146161B (no) | Analogifremgangsmaate til fremstilling av et terapeutisk aktivt alkyltiofenoksypropanolamin | |
Miyamato et al. | Secretase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 120256 Country of ref document: FI |
|
MA | Patent expired |